1. Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial. Issue 7 (7th July 2021) Authors: Francois, Bruno; Lambden, Simon; Gibot, Sebastien; Derive, Marc; Olivier, Aurelie; Cuvier, Valerie; Witte, Stephan; Grouin, Jean-Marie; Garaud, Jean Jacques; Salcedo-Magguilli, Margarita; Levy, Mitchell; Laterre, Pierre-François Journal: BMJ open Issue: Volume 11:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗